International Society for Biological and Environmental Repositories, Kensington, MD, USA
Br Med Bull. 2015 Jun;114(1):29-38. doi: 10.1093/bmb/ldv012. Epub 2015 Apr 24.
Biobanking refers to the infrastructure, policies and practices involved in collecting, processing, storing and disseminating biological samples. Biospecimen methods research to support biobanking through evidence-based practices is now recognized as critical to the success of biobanking and translational research.
Data concerning biospecimen research have appeared in the literature for many years, primarily in journals and textbooks focused on clinical chemistry, epidemiology and pathology. Recently, new efforts have been initiated to support the development of evidence-based biobanking practices.
Generally, researchers who are engaged in studies involving biospecimen collection are aware of the effects of pre-analytical variables on their downstream analyses, and they normally take steps to control those variables to publish reproducible results. Knowledge of such biospecimen research data is often unknown in the clinical setting unless the researchers are engaged in a project requiring strict protocols.
There is broad agreement of the need to develop evidence-based practices to achieve consistent quality for biospecimens and data. However, due to inconsistencies in the literature, there is some disagreement on whether biospecimens need to be collected according to a 'platinum' standard or local biobank standards for collecting samples as 'fit-for-purpose' will be sufficient.
New and expanded efforts, on an international basis where possible, need to be developed to better harmonize biospecimen management practices.
Additional biospecimen methods research leading to the development of evidence-based practices is critical to translational research and personalized medicine.
生物库是指收集、处理、存储和分发生物样本所涉及的基础设施、政策和实践。通过循证实践支持生物库的生物标本方法研究现在被认为是生物库和转化研究成功的关键。
多年来,关于生物标本研究的数据一直出现在文献中,主要是在专注于临床化学、流行病学和病理学的期刊和教科书中。最近,已经开始新的努力来支持循证生物库实践的发展。
通常,从事涉及生物样本采集的研究的研究人员都意识到分析前变量对下游分析的影响,并且他们通常会采取措施控制这些变量以发表可重复的结果。除非研究人员参与需要严格协议的项目,否则临床环境中通常不知道此类生物标本研究数据。
人们广泛认为需要制定循证实践,以实现生物标本和数据的一致质量。然而,由于文献中的不一致性,对于生物标本是否需要按照“白金”标准或当地生物库标准收集,还是“适合目的”的样本就足够了,存在一些分歧。
需要在国际基础上制定新的和扩展的努力,以更好地协调生物标本管理实践。
开展更多的生物标本方法研究,制定循证实践,对于转化研究和个性化医疗至关重要。